PATHOLOGICAL OUTCOME OF HER2 NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY. FMHR 2025, 3 (7), 1552-1558.